Atlas Trials

Median Effective Dose of Esketamine Pretreatment to Prevent Sufentanil-induced Cough

Clinical trial NCT05809804 · UNKNOWN

Trial details

NCT number
NCT05809804
Sponsor
Yangzhou University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
SufentanilEsketamine
Start date
2023-04-01
Primary completion
2023-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.